Trevi Therapeutics, Inc. ( TRVI) - Key Metrics
TRVI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.11 | -$0.11 | -$0.11 |
| 2026Q1 | $0 | -$0.09 | -$0.11 | -$0.12 |
| 2025Q4 | $0 | -$0.06 | -$0.05 | $0.04 |
| 2025Q3 | $0 | -$0.08 | -$0.07 | -$0.08 |
| 2025Q2 | $0 | -$0.09 | -$0.08 | -$0.08 |
TRVI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -42.39 |
| 2026Q1 | 0% | -32.92 |
| 2025Q4 | 0% | -54.72 |
| 2025Q3 | 0% | -28.59 |
| 2025Q2 | 0% | -14.49 |
TRVI
Price: $18.46
52 week price:
Earnings Per Share: -0.35 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 28000
Market Capitalization: 2.5 billion